Technical Analysis of (NSE: SUNPHARMA) Sun Pharmaceutical Industries Limited:
The technical looks that the major trend is bullish and in short-term price trending into downside, we have a recent bullish breakout, after forming a double bottom, which short-term support zone will be formed at 589, MACD start showing bullish divergence anticipation for upside for long-term
Let’s TALK ABOUT FUNDAMENTALS:
We have recent news that company growing enormously in foreign lands, and recently launching much product in the US, and europian markets:
If we look at the fundamentals of the company, we found that company growing continuously as we having 3.83% return in monthly profile and 25.27% return in yearly profile
Stock DNA show that company have the better return as compare to Sensex and company also paying dividends
PE:43 looks like overweighted, but as we discuss in the technical analysis section that chart having a good correction from last swing high and resting near to 52Week low which is at 434, and we also look in the image that average industry PE will be 60, so we found safe in this scenario for long run.